BMRN
Biomarin Pharmaceutical Inc
Price:  
58.82 
USD
Volume:  
1,670,126.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin DCF Valuation - Growth Exit 5Y

42.8%
Upside

What is the DCF valuation of Biomarin??

The Discounted Cash Flow (DCF) valuation of Biomarin Pharmaceutical Inc (BMRN) is 84.00 USD. With the latest stock price at 58.82 USD, the upside of Biomarin Pharmaceutical Inc based on DCF is 42.8%.

Is Biomarin a buy or a sell?

Based on the latest price of 58.82 USD and our DCF valuation, Biomarin Pharmaceutical Inc (BMRN) is a buy. buying Biomarin stocks now will result in a potential gain of 42.8%.

Range Selected
WACC / Discount Rate 6.1% - 8.1% 7.1%
Long-term Growth Rate 3.0% - 5.0% 4.0%
Fair Price 53.57 - 222.20 84.00
Upside -8.9% - 277.8% 42.8%
58.82 USD
Stock Price
84.00 USD
Fair Price